Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/30434
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAta, Barış-
dc.contributor.authorNamusoğlu, Sezcan-
dc.contributor.authorSeyhan, Ayşe-
dc.contributor.authorKaspoğlu, Işıl-
dc.contributor.authorUrman, Bülent-
dc.contributor.authorBozdağ, Gürkan-
dc.date.accessioned2023-01-12T12:50:35Z-
dc.date.available2023-01-12T12:50:35Z-
dc.date.issued2017-05-03-
dc.identifier.citationAta, B. vd. (2017). ''Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas''. Human Reproduction, 32(7), 1427-1431.en_US
dc.identifier.issn0268-1161-
dc.identifier.urihttps://doi.org/10.1093/humrep/dex099-
dc.identifier.urihttps://academic.oup.com/humrep/article/32/7/1427/3819244-
dc.identifier.uri1460-2350-
dc.identifier.urihttp://hdl.handle.net/11452/30434-
dc.description.abstractAre live birth rates (LBR) different after ART cycles between women with primary or recurrent endometrioma? Women with recurrent endometrioma have similar LBR as compared to patients with primary endometrioma. Recurrence rate can be as high as 29% after endometrioma excision. Prior studies on management of endometrioma before ART involve primary endometriomas. There is limited information regarding the prognosis of women with recurrent endometriomas. A multicenter retrospective cohort study, including 76 women with primary and 82 women with recurrent endometriomas treated at the participating centers over a 6-year period. Women with endometrioma who underwent ART at three academic ART centers. Couples with another indication for ART were excluded. Female age, median number of prior failed ART cycles, proportion of patients with bilateral endometrioma (28 versus 28.9%), ovarian stimulation protocols, and total gonadotropin consumption were similar between the study groups. Numbers of metaphase two oocytes (5 versus 6), number of embryos transferred, and the proportion of patients undergoing blastocyst transfer were similar across the study groups. Clinical pregnancy rates (36.6 versus 34.2%, absolute difference 2.4%, 95% CI: -12.5 to 17.3%, P = 0.83) and LBR (35.4 versus 30.3%, absolute difference 5.1%, 95% CI: -9.5 to 19.7%, P = 0.51) per started cycle in recurrent and primary endometrioma were similar. Comparable success rates were also confirmed with logistic regression analysis (OR: 1.14, 95% CI: 0.78-0.57, P = 2.3) The retrospective design has inherent limitations. Some women with severely decreased ovarian reserve after primary endometrioma excision may not have pursued further treatment. The management of endometrioma prior to ART is controversial but a different management strategy is not required for recurrent endometriomas. Since recurrent endometriomas do not have a worse impact on ART outcome than primary endometriomas, and repeat surgery has a higher risk for complications, conservative management without surgery can be justified.en_US
dc.language.isoenen_US
dc.publisherOxford Universityen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectObstetrics & gynecologyen_US
dc.subjectReproductive biologyen_US
dc.subjectAssisted reproductionen_US
dc.subjectEndometriosisen_US
dc.subjectInfertilityen_US
dc.subjectLive birthen_US
dc.subjectOvarian reserveen_US
dc.subjectNecurrent endometriomaen_US
dc.subjectOvarian reserveen_US
dc.subjectImpacten_US
dc.subjectExcisionen_US
dc.subjectIvfen_US
dc.subjectSurgeryen_US
dc.subjectRemovalen_US
dc.subjectCyclesen_US
dc.subject.meshAdulten_US
dc.subject.meshBirth rateen_US
dc.subject.meshCohort studiesen_US
dc.subject.meshElectronic health recordsen_US
dc.subject.meshEndometriosisen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInfertility, femaleen_US
dc.subject.meshLogistic modelsen_US
dc.subject.meshOrgan sparing treatmentsen_US
dc.subject.meshOvarian reserveen_US
dc.subject.meshPostoperative complicationsen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPregnancy rateen_US
dc.subject.meshRecurrenceen_US
dc.subject.meshReproductive techniques, assisteden_US
dc.subject.meshRetrospective studiesen_US
dc.subject.meshRisken_US
dc.subject.meshSeverity of illness indexen_US
dc.subject.meshTurkeyen_US
dc.subject.meshAcademic medical centersen_US
dc.titleWhich is worse? Comparison of ART outcome between women with primary or recurrent endometriomasen_US
dc.typeArticleen_US
dc.identifier.wos000404889000009tr_TR
dc.identifier.scopus2-s2.0-85021811887tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-9277-7735tr_TR
dc.identifier.startpage1427tr_TR
dc.identifier.endpage1431tr_TR
dc.identifier.volume32tr_TR
dc.identifier.issue7tr_TR
dc.relation.journalHuman Reproductionen_US
dc.contributor.buuauthorAslan, Kiper-
dc.contributor.buuauthorAvcı, Berrin-
dc.contributor.buuauthorUncu, Gürkan-
dc.contributor.researcheridAER-7173-2022tr_TR
dc.contributor.researcheridAAH-9694-2021tr_TR
dc.contributor.researcheridABE-6685-2020tr_TR
dc.contributor.researcheridAAT-3479-2021tr_TR
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed28498960tr_TR
dc.subject.wosObstetrics & gynecologyen_US
dc.subject.wosReproductive biologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ1en_US
dc.contributor.scopusid56740498500tr_TR
dc.contributor.scopusid55769899600tr_TR
dc.contributor.scopusid6603716169tr_TR
dc.subject.scopusDienogest; Ovarian Reserve; Elagolixen_US
dc.subject.emtreeGonadotropinen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBlastocysten_US
dc.subject.emtreeConservative treatmenten_US
dc.subject.emtreeEmbryo transferen_US
dc.subject.emtreeEndometrium tumoren_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInfertility therapyen_US
dc.subject.emtreeLaparoscopyen_US
dc.subject.emtreeLaparotomyen_US
dc.subject.emtreeLive birthen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMetaphaseen_US
dc.subject.emtreeNidationen_US
dc.subject.emtreeOocyteen_US
dc.subject.emtreeOvarian reserveen_US
dc.subject.emtreePregnancy rateen_US
dc.subject.emtreePrognosisen_US
dc.subject.emtreeRecurrence risken_US
dc.subject.emtreeRecurrent diseaseen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeBirth rateen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeCohort analysisen_US
dc.subject.emtreeComparative studyen_US
dc.subject.emtreeElectronic health recorden_US
dc.subject.emtreeEndometriosisen_US
dc.subject.emtreeFemale infertilityen_US
dc.subject.emtreeInfertility therapyen_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreePathophysiologyen_US
dc.subject.emtreePostoperative complicationen_US
dc.subject.emtreePregnancyen_US
dc.subject.emtreeRecurrent diseaseen_US
dc.subject.emtreeRisken_US
dc.subject.emtreeSeverity of illness indexen_US
dc.subject.emtreeStatistical modelen_US
dc.subject.emtreeUniversity hospitalen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Eslan_vd_2017.pdf145.08 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons